Risultati della ricerca - Beate Wulff

Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Cli... di Michael Boyiadzis, Andrew H. Wei, Bruno Paiva, Sylvie D. Freeman, Gertjan Kaspers, Brenda Chyla, Sarah Hersey, Reshma Patel, Brian Maloney, Marie‐Helene Blanchet Zumofen, Marlies Van Hoef, Beate Wulff, Vanessa Obourn, Shalaka Patel, Daniel Lopes de Menezes, Qian Shi, Bourras‐Rezki Bengoudifa, Natalie Dimier, Thomas J. Prior, Gail J. Roboz, Thomas Prebet

Testo